|
Sep 26
|
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
|
|
Sep 26
|
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
|
|
Sep 26
|
EU regulator recommends suspension of Pfizer's sickle cell disease treatment
|
|
Sep 26
|
Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety Concerns
|
|
Sep 26
|
Pfizer Voluntarily Withdraws Sickle Cell Disease Treatment Oxbryta From Global Market Due To Painful Disease Complication, Deaths (UPDATED)
|
|
Sep 26
|
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
|
|
Sep 26
|
2 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
|
|
Aug 30
|
2 Incredibly Cheap Healthcare Stocks to Buy Now
|
|
Aug 29
|
GSK's RSV Vaccine Arexvy Gets EU Nod for Adults Aged 50-59 Years
|
|
Aug 29
|
New COVID vaccines are here. What to know about the latest shots as summer surge continues
|
|
Aug 29
|
Why Is Pfizer (PFE) Down 5.9% Since Last Earnings Report?
|
|
Aug 29
|
Flagship, Quotient and Pfizer link on cardiovascular and renal disease
|
|
Aug 28
|
Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs
|
|
Aug 28
|
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
|
|
Aug 28
|
2 Beaten-Down S&P 500 Dividend Stocks to Buy on the Dip and Hold Forever
|
|
Aug 28
|
Pfizer launches digital healthcare platform to streamline access
|
|
Aug 27
|
Why Walgreens Boots Alliance Plunged Today
|
|
Aug 27
|
Pfizer launches new telehealth and prescription drug platform
|
|
Aug 27
|
From Big Pharma Headquarters To Apartments: The Plans For NYC's Biggest Office Conversion Yet
|
|
Aug 27
|
Eli Lilly slashes Zepbound prices for self-pay patients
|